Daniel Salamon

Publications
CV
Public outreach and news

Articles

Article: ENDOCRINOLOGY. 2023;165(1):bqad174

DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells.

Salamon D; Ujvari D; Hellberg A; Hirschberg AL
Article: ONCOIMMUNOLOGY. 2022;11(1):2109861

IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors.

Ujvari D; Malyukova A; Zovko A; Yektaei-Karin E; Madapura HS; Keszei M; Nagy N; Lotfi K; Björn N; Wallvik J; Stenke L; Salamon D
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2021;25(20):9523-9532

Interaction between insulin and androgen signalling in decidualization, cell migration and trophoblast invasion in vitro.

Hirschberg AL; Jakson I; Graells Brugalla C; Salamon D; Ujvari D
Article: CELL DEATH & DISEASE. 2021;12(10):875

Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.

Malyukova A; Ujvari D; Yektaei-Karin E; Zovko A; Madapura HS; Keszei M; Nagy N; Lotfi K; Björn N; Wallvik J; Tamai M; Nguyen TTT; Akahane K; Inukai T; Stenke L; Salamon D
Journal article: HEMATO. 2021;2(1):154-166

Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin

Lasaviciute G; Hoebinger A; Ujvari D; Salamon D; Yusuf A; Sundin M; Sverremark-Ekstroem E; Chikhi R; Nilsson A; Saghafian-Hedengren S
Article: ONCOLOGY REPORTS. 2018;40(2):902-908

Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.

Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2018;498(3):502-508

Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells.

Ujvari D; Nagy N; Madapura HS; Kallas T; Kröhnke MCL; Stenke L; Klein E; Salamon D
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2018;22(1):163-172

Prokineticin 1 is up-regulated by insulin in decidualizing human endometrial stromal cells.

Ujvari D; Jakson I; Oldmark C; Attarha S; Alkasalias T; Salamon D; Gidlöf S; Hirschberg AL
Article: ONCOGENE. 2017;36(32):4619-4628

Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.

Madapura HS; Nagy N; Ujvari D; Kallas T; Kröhnke MCL; Amu S; Björkholm M; Stenke L; Mandal PK; McMurray JS; Keszei M; Westerberg LS; Cheng H; Xue F; Klein G; Klein E; Salamon D
Article: PLOS ONE. 2017;12(1):e0171004

Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1.

Ujvari D; Jakson I; Babayeva S; Salamon D; Rethi B; Gidlöf S; Hirschberg AL
Article: METHODS IN MOLECULAR BIOLOGY. 2017;1532:207-213

Analysis of Viral Epigenotypes Using Bisulfite Sequencing: A Detailed Protocol for the Crucial Bisulfite Modification and PCR Amplification Steps.

Salamon D
Article: CELL CYCLE. 2016;15(9):1267-1275

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.

Madapura HS; Salamon D; Wiman KG; Lain S; Klein E; Nagy N
Article: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 2016;879:39-69

Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.

Niller HH; Banati F; Salamon D; Minarovits J
Article: JOURNAL OF VIROLOGY. 2014;88(6):3235-3245

T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice.

Heuts F; Rottenberg ME; Salamon D; Rasul E; Adori M; Klein G; Klein E; Nagy N
Article: GENOME RESEARCH. 2014;24(2):177-184

Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.

Hansen KD; Sabunciyan S; Langmead B; Nagy N; Curley R; Klein G; Klein E; Salamon D; Feinberg AP
Article: PLOS ONE. 2014;9(8):e106008

The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.

Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;435(1):8-15

The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.

Szenthe K; Koroknai A; Banati F; Bathori Z; Niller HH; Wolf H; Nagy N; Klein E; Minarovits J; Salamon D
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;433(4):489-495

The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Article: CELL CYCLE. 2012;11(24):4563-4569

p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP.

Madapura HS; Salamon D; Wiman KG; Lain S; Klein G; Klein E; Nagy N
Article: JOURNAL OF VIROLOGY. 2012;86(8):4701-4707

Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Salamon D; Adori M; Ujvari D; Wu L; Kis LL; Madapura HS; Nagy N; Klein G; Klein E
Article: CYTOKINE. 2012;57(3):360-371

Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.

Salamon D; Adori M; He M; Bönelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(5):1512-1517

Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Nagy N; Adori M; Rasul A; Heuts F; Salamon D; Ujvári D; Madapura HS; Leveau B; Klein G; Klein E
Article: BLOOD. 2011;117(1):165-174

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.

Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(2):872-877

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.

Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Article: JOURNAL OF GENERAL VIROLOGY. 2009;90(Pt 5):1183-1189

Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.

Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
Article: JOURNAL OF GENERAL VIROLOGY. 2008;89(Pt 6):1364-1370

Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.

Fejer G; Koroknai A; Banati F; Györy I; Salamon D; Wolf H; Niller HH; Minarovits J
Article: EUROPEAN JOURNAL OF CANCER. 2008;44(7):1030-1038

Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.

Szalmás A; Bánáti F; Koroknai A; László B; Fehér E; Salamon D; Gergely L; Minárovits J; Kónya J
Article: FEBS LETTERS. 2008;582(5):705-709

CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus.

Banati F; Koroknai A; Salamon D; Takacs M; Minarovits-Kormuta S; Wolf H; Niller HH; Minarovits J
Article: JOURNAL OF VIROLOGY. 2007;81(23):13242-13247

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Gerle B; Koroknai A; Fejer G; Bakos A; Banati F; Szenthe K; Wolf H; Niller HH; Minarovits J; Salamon D
Article: VIRUS GENES. 2007;35(2):195-202

High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Article: JOURNAL OF BACTERIOLOGY. 2006;188(19):6932-6942

Rem, a new transcriptional activator of motility and chemotaxis in Sinorhizobium meliloti.

Rotter C; Mühlbacher S; Salamon D; Schmitt R; Scharf B
Article: MEDICAL HYPOTHESES. 2004;62(3):387-391

EBV-associated neoplasms: alternative pathogenetic pathways.

Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
Article: ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA. 2004;51(4):469-484

A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review.

Niller HH; Salamon D; Rahmann S; Ilg K; Koroknai A; Bánáti F; Schwarzmann F; Wolf H; Minárovits J
Article: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2003;111(8):486-490

Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia.

Speer G; Tóth M; Niller H-H; Salamon D; Takács I; Miheller P; Patócs A; Nagy Z; Bajnok E; Nyiri P; Lakatos P
Journal article: ORVOSI HETILAP. 2003;144(41):2029-2031

[Familial hypocalciuric hypercalcemia].

Tóth M; Speer G; Patócs A; Salamon D; Lakatos P; Rácz K; Tulassay Z
Article: VIRUS GENES. 2003;27(1):57-66

High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.

Salamon D; Takacs M; Schwarzmann F; Wolf H; Minarovits J; Niller HH
Article: MEDICAL SCIENCE MONITOR. 2003;9(1):HY1-HY9

The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.

Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Article: JOURNAL OF VIROLOGY. 2002;76(8):4113-4118

Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Niller HH; Salamon D; Uhlig J; Ranf S; Granz M; Schwarzmann F; Wolf H; Minarovits J
Article: BIOLOGICAL CHEMISTRY. 2001;382(10):1411-1419

Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.

Niller HH; Salamon D; Takacs M; Uhlig J; Wolf H; Minarovits J
Article: BIOLOGICAL CHEMISTRY. 2001;382(4):699-705

Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.

Takacs M; Salamon D; Myöhänen S; Li H; Segesdi J; Ujvari D; Uhlig J; Niller HH; Wolf H; Berencsi G; Minarovits J
Article: ONCOLOGY. 2000;58(3):242-247

Vitamin D receptor gene BsmI polymorphism correlates with erbB-2/HER-2 expression in human rectal cancer.

Speer G; Dworak O; Cseh K; Bori Z; Salamon D; Török I; Winkler G; Vargha P; Nagy Z; Takács I; Kucsera M; Lakatos P
Article: BIOLOGICAL CHEMISTRY. 2000;381(2):95-105

De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes.

Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 1998;42(3):169-174

Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.

Winkler G; Salamon F; Harmos G; Salamon D; Speer G; Szekeres O; Hajós P; Kovács M; Simon K; Cseh K
Show more

All other publications

Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;90(6)

GDF-15 as an alternative survival-factor for antibody-producing cells during chemotherapy

Lasaviciute G; Ujvari D; Salamon D; Eksborg S; Sundin M; Sverremark-Ekstrom E; Nilsson A; Saghafian-Hedengren S
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):270

The influence of chemotherapy on plasma cell survival niche and serological memory

Lasaviciute G; Ujvari D; Salamon D; Eksborg S; Sundin M; Sverremark-Ekstrom E; Saghafian-Hedengren S; Nilsson A
Preprint: PREPRINTS.ORG. 2016

Up-regulation of Lamin A/C Expression in Epstein-Barr Virus Immortalized B Cells and Burkitt Lymphoma Cell Lines of Activated B Cell Phenotype

Bánáti F; Koroknai A; Szenthe K; Tereh T; Kovács N; Hidasi A; Bánkuti B; Buzás K; Lemnitzer F; Ruzsics Z; Szathmary S; Wolf H; Salamon D; Minárovits J; Niller H-H
Conference publication: GYNECOLOGICAL ENDOCRINOLOGY. 2016;32:69

Insulin modulates in vitro decidualization of human endometrial stromal cells via transcriptional inhibition of Forkhead box protein O1 (FOXO1)

Ujvari D; Jakson I; Babayeva S; Salamon D; Rethi B; Gidloef S; Hirschberg AL
Review: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2010;1799(3-4):228-235

Epigenetic regulation of latent Epstein-Barr virus promoters.

Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Editorial comment: TRENDS IN MICROBIOLOGY. 2004;12(11):495-499

The LCR of EBV makes Burkitt's lymphoma endemic.

Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Review: JOURNAL OF VIROLOGY. 2001;75(6):2584-2596

Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Salamon D; Takacs M; Ujvari D; Uhlig J; Wolf H; Minarovits J; Niller HH
Letter: DIABETOLOGIA. 1998;41(7):860-861

Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.

Winkler G; Salamon F; Salamon D; Speer G; Simon K; Cseh K
Letter: DIABETOLOGIA. 1998;41(4):488

Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus.

Winkler G; Dworak O; Salamon F; Salamon D; Speer G; Cseh K
Letter: DIABETES CARE. 1997;20(12):1923-1924

Intimal-medical thickness of the carotid artery in NIDDM patients.

Winkler G; Salamon F; Porochnavec M; Solymosi D; Demeter J; Simon K; Salamon D; Karádi I; Cseh K; Romics L

Employments

Senior Research Specialist, Department of Women's and Children's Health, Karolinska Institutet, 2022-

Degrees and Education

Docent, Karolinska Institutet, 2022

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI